Home/Filings/4/0000878526-21-000008
4//SEC Filing

Kennedy Jonathan 4

Accession 0000878526-21-000008

CIK 0000878526other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:17 PM ET

Size

10.3 KB

Accession

0000878526-21-000008

Insider Transaction Report

Form 4
Period: 2020-12-31
Kennedy Jonathan
Sr. VP, CFO
Transactions
  • Other

    Common Stock, $0.001 par value per share

    2020-12-31$20.04/sh22,695$454,808139,590 total
  • Award

    Common Stock, $0.001 par value per share

    2021-01-04$20.61/sh+66,716$1,375,017191,321 total
  • Award

    Non-qualified Stock Option

    2021-01-04+66,71666,716 total
    Exercise: $20.61From: 2022-01-04Exp: 2031-01-04Common Stock (66,716 underlying)
  • Tax Payment

    Common Stock, $0.001 par value per share

    2021-01-02$20.04/sh14,985$300,299124,605 total
Footnotes (3)
  • [F1]Performance Restricted Stock cancelled previously reported on the August 2018 Form 4 due to performance goals not met.
  • [F2]Restricted Stock Awards vest 25% on the anniversary of the grant over 4 years. Includes a total of 16,679 shares deferred pursuant to the terms of the deferred stock grant under Natus' Non-Qualified Deferred Compensation Plan.
  • [F3]Stock Options vest 25% on the anniversary of the grant over 4 years.

Issuer

NATUS MEDICAL INC

CIK 0000878526

Entity typeother

Related Parties

1
  • filerCIK 0001451629

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:17 PM ET
Size
10.3 KB